Vaderis Therapeutics closes $152 million Series B financing to support its global Phase 3 HEROIC study for engasertib in hereditary hemorrhagic telangiectasia.
Amount Raised
$152 Million
Round Type
Series B
Investors
Description
Vaderis Therapeutics has secured $152 million in an oversubscribed Series B financing. This funding will facilitate the initiation of the HEROIC Phase 3 clinical study for engasertib targeting hereditary hemorrhagic telangiectasia. The financing involved both new and existing investors, highlighting confidence in the drug's potential. Proceeds are expected to support operations through regulatory submissions and potential U.S
Quick answer
Vaderis Therapeutics raised $152 Million in a Series B round, dated August 11, 2026. Investors: Omega Funds, Tcgx, Goldman Sachs Alternatives and Medicxi.
- How much did Vaderis Therapeutics raise?
- Vaderis Therapeutics raised $152 Million in a Series B round on August 11, 2026.
- Who invested in Vaderis Therapeutics?
- Omega Funds, Tcgx, Goldman Sachs Alternatives and Medicxi are named as investors in this round.
- What does Vaderis Therapeutics do?
- Vaderis Therapeutics is a clinical-stage biopharmaceutical company focused on developing targeted therapies for rare vascular diseases.
- Where is Vaderis Therapeutics based and how big is it?
- Fundz records about 19 employees.
- Who are the decision-makers at Vaderis Therapeutics?
- Fundz holds 1 contact at Vaderis Therapeutics, including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Vaderis Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised $6.4M on September 8, 2026.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
- Apollomics raised $10M on August 14, 2026.
- Os Therapies raised $5M on August 10, 2026.
Who to call at Vaderis Therapeutics, and when
A new round usually means Vaderis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vaderis Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vaderis Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vaderis Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vaderis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVaderis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.